Market Closed -
Nasdaq
16:00:00 2024-05-10 EDT
|
5-day change
|
1st Jan Change
|
3.55
USD
|
-1.39%
|
|
+13.42%
|
+184.00%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
54.26
|
31.14
|
35.36
|
17.61
|
8.495
|
45.74
|
-
|
-
|
Enterprise Value (EV)
1 |
54.26
|
31.14
|
35.36
|
17.61
|
8.495
|
45.74
|
45.74
|
45.74
|
P/E ratio
|
-
|
-6.92
x
|
-
|
-2.39
x
|
-1.04
x
|
-7.72
x
|
-7.98
x
|
-7.4
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
244
x
|
-
|
48.9
x
|
69
x
|
37.6
x
|
76.8
x
|
93.8
x
|
78.3
x
|
EV / Revenue
|
244
x
|
-
|
48.9
x
|
69
x
|
37.6
x
|
76.8
x
|
93.8
x
|
78.3
x
|
EV / EBITDA
|
-14,296,341
x
|
-
|
-6,342,044
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-14,858,565
x
|
-
|
-8,689,172
x
|
-
|
-1,436,253
x
|
-
|
-
|
-
|
FCF Yield
|
-0%
|
-
|
-0%
|
-
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
2,621
|
3,001
|
5,685
|
5,951
|
8,092
|
12,886
|
-
|
-
|
Reference price
2 |
20.70
|
10.38
|
6.220
|
2.960
|
1.050
|
3.550
|
3.550
|
3.550
|
Announcement Date
|
19-11-14
|
20-10-14
|
21-11-29
|
22-11-28
|
23-11-20
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.2226
|
-
|
0.7227
|
0.2554
|
0.2262
|
0.596
|
0.4875
|
0.5845
|
EBITDA
|
-3.795
|
-
|
-5.575
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
-7.384
|
-6.534
|
-5.378
|
-7.398
|
-9.14
|
Operating Margin
|
-
|
-
|
-
|
-2,891.01%
|
-2,888.48%
|
-902.35%
|
-1,517.54%
|
-1,563.73%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-7.384
|
-6.713
|
-5.4
|
-7.379
|
-9.14
|
Net income
1 |
-
|
-3.934
|
-
|
-7.384
|
-6.665
|
-5.4
|
-7.379
|
-9.14
|
Net margin
|
-
|
-
|
-
|
-2,891.01%
|
-2,946.33%
|
-906.04%
|
-1,513.64%
|
-1,563.73%
|
EPS
2 |
-
|
-1.500
|
-
|
-1.240
|
-1.010
|
-0.4600
|
-0.4450
|
-0.4800
|
Free Cash Flow
|
-3.652
|
-
|
-4.069
|
-
|
-5.915
|
-
|
-
|
-
|
FCF margin
|
-1,640.42%
|
-
|
-563.02%
|
-
|
-2,614.82%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-11-14
|
20-10-14
|
21-11-29
|
22-11-28
|
23-11-20
|
-
|
-
|
-
|
Fiscal Period: August |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
0.0306
|
0.0997
|
0.1112
|
-
|
0.0932
|
-0.00343
|
0.1513
|
0.145
|
0.15
|
0.15
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-1.449
|
-2.418
|
-1.513
|
-
|
-2.384
|
-1.071
|
-1.139
|
-0.668
|
-1.663
|
-1.908
|
Operating Margin
|
-4,726.49%
|
-2,425.13%
|
-1,361.37%
|
-
|
-2,558.85%
|
31,210.2%
|
-753%
|
-460.7%
|
-1,108.67%
|
-1,272%
|
Earnings before Tax (EBT)
1 |
-1.449
|
-2.418
|
-1.513
|
-
|
-2.384
|
-1.249
|
-1.185
|
-0.6527
|
-1.663
|
-1.908
|
Net income
1 |
-1.426
|
-2.383
|
-1.513
|
-1.298
|
-2.372
|
-1.239
|
-1.179
|
-0.6495
|
-1.663
|
-1.908
|
Net margin
|
-4,651.81%
|
-2,389.62%
|
-1,361.37%
|
-
|
-2,545.9%
|
36,131.78%
|
-779.56%
|
-447.96%
|
-1,108.67%
|
-1,272%
|
EPS
2 |
-0.2500
|
-0.4100
|
-0.2400
|
-0.2200
|
-0.3700
|
-0.1200
|
-0.1300
|
-0.0600
|
-0.1300
|
-0.1250
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-04-11
|
22-07-14
|
22-11-28
|
23-04-14
|
23-07-14
|
23-11-20
|
24-01-12
|
24-04-09
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-3.65
|
-
|
-4.07
|
-
|
-5.91
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
0.03
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
14.92%
|
-
|
-
|
-
|
Announcement Date
|
19-11-14
|
20-10-14
|
21-11-29
|
22-11-28
|
23-11-20
|
-
|
-
|
-
|
Last Close Price
3.55
USD Average target price
10
USD Spread / Average Target +181.69% Consensus |
1st Jan change
|
Capi.
|
---|
| +184.00% | 45.74M | | +30.38% | 684B | | +26.51% | 568B | | -4.36% | 361B | | +19.30% | 329B | | +3.73% | 284B | | +16.70% | 240B | | +8.78% | 208B | | -7.93% | 200B | | +7.68% | 166B |
Other Pharmaceuticals
|